Do worldwide outbreaks mean tuberculosis again becomes 'captain of all these men of death'?

Article Abstract:

The incidence of drug-resistant tuberculosis is higher in patients who are infected with the human immunodeficiency virus (HIV). Before 1984, 10% of tuberculosis bacteria taken from patients were drug-resistant, but the number increased to 52% after 1984. Individuals infected with HIV are more vulnerable to tuberculosis infection and are more likely to develop active tuberculosis than healthy individuals. Tests to detect tuberculosis infection are often unreliable in HIV-infected individuals. New York State public health officials are trying to identify individuals exposed to drug-resistant tuberculosis, and are screening prisoners for the disease. Treatment of tuberculosis patients is difficult because of poor patient compliance, and several anti-tuberculosis drugs are not available. The Centers for Disease Control wants pharmaceutical companies to develop more effective drugs. Public health experts are considering the use of a tuberculosis vaccine in high-risk individuals, and New York State may open a sanitarium for tuberculosis patients.

Drug therapy, Tuberculosis

---

Animal Feed Antibiotic Use Raises Drug Resistance Fear

Article Abstract:

Scientists, physicians, and policymakers met at Georgetown University in Washington, DC, to discuss the human health implications of antibiotic use in feed animals. Antibiotics used to promote growth in cattle and other feed animals may encourage the development of drug-resistant organisms. The use of virginiamycin, a new antibiotic drug, has resulted in poultry that harbor bacteria resistant to Synercid, a new antibiotic intended to treat vancomycin-resistant enterococcal infections.

Health aspects, Statistical Data Included, Usage, Antibiotics, Antibiotics in animal nutrition, Animal nutrition, Veterinary antibiotics, Synercid (Medication)

---

Protecting Subjects of Clinical Research

Article Abstract:

The National Bioethics Advisory Commission has recommended that the Office of Protection From Reseach Risks (OPRR) be moved to the Department of Health and Human Services and expanded. Research subjects in medical clinical trials only receive the protective oversight of OPRR if the study is federally funded. In order to improve the safety of human experimentation, the Commission recommends that all research, funded publicly or privately, should be overseen by OPRR.

Laws, regulations and rules, Services, Clinical trials, United States. National Institutes of Health, Human experimentation in medicine, Human medical experimentation

Similar abstracts:

• Abstracts: Transmission of tuberculosis among the urban homeless. Molecular epidemiology of tuberculosis. Patterns of tuberculosis transmission in Central Los Angeles
• Abstracts: Pancreatitis and mutations of the cystic fibrosis gene. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
• Abstracts: Prevalence of shoulder pain in the community: the influence of case definition. The occurrence of falls among patients with a new episode of hip pain
• Abstracts: New treatment for ethylene glycol poisoning. Fomepizole for the treatment of methanol poisoning. Fomepizole for the treatment of ethylene glycol poisoning
• Abstracts: Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.